Thurston Springer Miller Herd & Titak Inc. decreased its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 22.5% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,039 shares of the company’s stock after selling 301 shares during the period. Thurston Springer Miller Herd & Titak Inc.’s holdings in GE HealthCare Technologies were worth $77,000 as of its most recent SEC filing.
Several other institutional investors have also recently bought and sold shares of GEHC. N.E.W. Advisory Services LLC bought a new stake in shares of GE HealthCare Technologies in the 1st quarter worth $25,000. Bogart Wealth LLC grew its position in GE HealthCare Technologies by 260.0% during the first quarter. Bogart Wealth LLC now owns 342 shares of the company’s stock valued at $28,000 after buying an additional 247 shares during the period. Stonebridge Financial Group LLC grew its position in GE HealthCare Technologies by 165.7% during the first quarter. Stonebridge Financial Group LLC now owns 356 shares of the company’s stock valued at $29,000 after buying an additional 222 shares during the period. Ameriflex Group Inc. bought a new position in GE HealthCare Technologies during the fourth quarter valued at about $31,000. Finally, Olde Wealth Management LLC bought a new position in GE HealthCare Technologies during the first quarter valued at about $35,000. Institutional investors and hedge funds own 82.06% of the company’s stock.
Get GE HealthCare Technologies alerts:
Analysts Set New Price Targets
Several equities analysts recently weighed in on GEHC shares. BTIG Research restated a “buy” rating on shares of GE HealthCare Technologies in a research report on Monday, July 14th. Zacks Research upgraded shares of GE HealthCare Technologies from a “hold” rating to a “strong-buy” rating in a research report on Thursday, August 28th. Wall Street Zen upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating in a research report on Saturday, May 31st. Morgan Stanley cut their target price on shares of GE HealthCare Technologies from $78.00 to $74.00 and set an “equal weight” rating for the company in a research report on Thursday, July 31st. Finally, Citigroup increased their target price on shares of GE HealthCare Technologies from $89.00 to $93.00 and gave the stock a “buy” rating in a research report on Thursday, July 31st. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $88.40.
Get Our Latest Report on GEHC
GE HealthCare Technologies Stock Down 1.1%
Shares of GE HealthCare Technologies stock opened at $76.63 on Thursday. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.93 and a current ratio of 1.16. GE HealthCare Technologies Inc. has a 52-week low of $57.65 and a 52-week high of $94.80. The stock has a market capitalization of $34.99 billion, a price-to-earnings ratio of 15.70, a P/E/G ratio of 2.96 and a beta of 1.13. The company’s 50 day moving average price is $74.59 and its 200-day moving average price is $73.42.
GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last issued its earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.91 by $0.15. The firm had revenue of $5 billion for the quarter, compared to analysts’ expectations of $4.96 billion. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The business’s revenue was up 3.5% on a year-over-year basis. During the same quarter last year, the business earned $1.00 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. Equities research analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.
GE HealthCare Technologies Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 25th were issued a $0.035 dividend. The ex-dividend date was Friday, July 25th. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies’s payout ratio is 2.87%.
About GE HealthCare Technologies
(Free Report)
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Featured Stories
Five stocks we like better than GE HealthCare Technologies
What Are Treasury Bonds?
Biotech Breakouts: 3 Stocks With Massive Upside Potential
How to trade using analyst ratings
Powering Up: A Buy Rating Signals GE Vernova’s AI Tailwinds
Insider Trades May Not Tell You What You Think
The Side of Rate Cuts Nobody Is Telling You About
Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report).